Physician’s Briefing Weekly Coronavirus Roundup
FDA Gives OK to Merck Antiviral At-Home COVID-19 Pill
Molnupiravir cut the risk for hospitalization and death in high-risk patients by 30 percent
Omicron Now Accounts for 73 Percent of New COVID-19 Cases
Rate suggests there were more than 650,000 omicron infections in the United States last week
2019 to 2020 Saw 16.8 Percent Increase in U.S. Death Rate
Age-specific death rates increased for each age group 15 years and older; COVID-19 became third leading cause of death in 2020
COVID-19 Certification Mandates May Increase Vaccine Uptake
Country-specific information, such as prior vaccination uptake, vaccine hesitancy may influence the effect of COVID-19 certification mandates
FDA Approves Pfizer Pill as First At-Home COVID-19 Treatment
Recent trial showed Paxlovid cut the odds for hospitalization and death by nearly 90 percent in high-risk people
Fresh Express Salad Mixes Tied to Multistate Listeria Outbreak
Outbreak has caused 10 illnesses, one hospitalization, and one death
U.S. Army Reports Progress on COVID-19 Vaccine That Fights All Variants
Animal studies have already shown new vaccine induces highly potent antibody responses against major variants
13 Million Adults Delaying or Skipping Meds Due to Costs
Drug unaffordability is an issue regardless of insurance status and across private, public payers
First Long-Acting Injectable Approved for HIV PrEP
Apretude, administered every two months, is approved in adults and adolescents at risk for HIV infection
